The Department of Justice (DOJ) will launch a set of updated rules called the Revised Protocol for the Case Management of ...

The Department of Justice (DOJ) on Thursday launched the revised protocols for the case management of child victims of abuse, neglect, and exploitation, which now also covers discrimination.

Madrigal Pharmaceuticals (NASDAQ:MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical for SYH2086, a new oral GLP-1 receptor agonist being developed as an obesity treatment. As ...

The Department of Justice (DOJ) on Tuesday said it would launch the revised protocol for the case management of child victims ...

Hong Kong-based CSPC will receive $120 million from Madrigal under the deal. Elsewhere, Apellis and PTC Therapeutics won FDA approvals.

CSPC has a very strong financial position. As of 2022, its total debt outstanding is only 1.8% of its total cash in hand. Its annual capital expenditure for 2022 was CNY 1.8 billion. Given its CNY ...

The idea is that SYH2086 can be paired with Rezdiffra, a selective thyroid hormone receptor agonist that became the first FDA-approved drug for metabolic dysfunction-associated steatohepatitis (MASH) ...

Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026.

ET Net News Agency, 12 August 2025] CSPC PHARMA (01093) fell 2.8% to HK$10.07. It hits an intra-day low of HK$10.02, and an intra-day high of HK$10.46. The total shares traded was 83.88 million, with ...

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

Access CSPC Pharma stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.